+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Discussion on Regulatory Risk of in Vitro Diagnostic Reagents in Use



Discussion on Regulatory Risk of in Vitro Diagnostic Reagents in Use



Zhongguo Yi Liao Qi Xie Za Zhi 42(1): 62-63



According to the information of the supervision and inspection of in vitro diagnostic reagents for clinical use, this article analyzed the compliance issues and discussed the methods to solve the problems, to urge medical institutions to reduce the regulatory risk of in vitro diagnostic reagents in use.

(PDF emailed within 1 workday: $29.90)

Accession: 058427101

Download citation: RISBibTeXText

PMID: 29862751


Related references

Discussion on Strengthening the Hospital Management of in Vitro Diagnostic Reagents. Zhongguo Yi Liao Qi Xie Za Zhi 40(3): 227-229, 2018

Study on the supervision of in-vitro diagnostic reagents. Zhongguo Yi Liao Qi Xie Za Zhi 35(1): 68-70, 2013

Studies on administration of in-vitro diagnostic reagents. Zhongguo Yi Liao Qi Xie Za Zhi 29(2): 124-130, 2005

A pilot study on the quality management system of in-vitro diagnostic reagents. Zhongguo Yi Liao Qi Xie Za Zhi 30(3): 199-205, 2006

Product class standards specifications and evaluation of microbiological in vitro diagnostic reagents. Prier, James E , Josephine Bartola And Herman Friedman (Ed ) Quality Control in Microbiology Symposium Philadelphia, Pa , U S A Nov 15-16, 1973 X+188p Illus University Park Press: Baltimore, Md , U S A ; London, England ISBN 0-8391-0766-8: 87-104, 1975

The Situation and Countermeasures of the Undocumented in Vitro Diagnostic Reagents Urgently Needed in Clinical. Zhongguo Yi Liao Qi Xie Za Zhi 39(5): 356-7, 366, 2016

Monoclonal antibodies to ricin: in vitro inhibition of toxicity and utility as diagnostic reagents. Hybridoma 24(5): 236-243, 2005

Model fluids representing aqueous in vitro diagnostic reagents for the development of dispensing systems. 2013

Model fluids representing aqueous in-vitro diagnostic reagents for the development of dispensing systems. Drug Discovery Today 18(21-22): 1035-1042, 2014

Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable. Official Gazette of the United States Patent & Trademark Office Patents 1269(1), Apr 1, 2003

Regulatory Forum Review*: Utility of in Vitro Secondary Pharmacology Data to Assess Risk of Drug-induced Valvular Heart Disease in Humans: Regulatory Considerations. Toxicologic Pathology 45(3): 381-388, 2017

Discussion about Management of In Vitro Diagnostic Reagent. Zhongguo Yi Liao Qi Xie Za Zhi 39(3): 232-234, 2015

Current status of diagnostic reagents for schistosomiasis in China--an analysis based on results from parallel examinations and check-up of methods/reagents. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 16(5): 321-325, 2002

DISCUSSION OF Aquifer Testing, Mathematical Modeling, and Regulatory Risk, by Ching-Pi Wang and Roy E. Williams. Groundwater 22(5): 620-623, 1984

FDA's new regulatory paradigms for in vitro diagnostic devices. CytoTherapy 1(4): 353-357, 2010